[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma

PHASE3TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

July 18, 2025

Study Completion Date

July 18, 2025

Conditions
Marginal Zone Lymphoma
Interventions
DRUG

[68Ga]Ga-PentixaFor

\[68Ga\]Ga-PTF i.v. injection

DRUG

[18F]Fluorodeoxyglucose

\[18F\]FDG i.v. injection.

Trial Locations (12)

6020

Medizinische Universität Innsbruck, Innsbruck

13005

CHU La Timone, Marseille

20132

Ospedale San Raffaele S.r.l., Milan

31008

Clinica Universidad de Navarra, Pamplona

33600

CHU de Bordeaux, Bordeaux

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

44093

CHU de Nantes, Nantes

45147

Universitätsklinikum Essen, Essen

47014

"L'IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori - IRST S.r.l", Meldola

75014

Hôpital Cochin, Paris

97080

Universitätsklinikum Würzburg, Würzburg

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Pivotal S.L.

INDUSTRY

lead

Pentixapharm AG

INDUSTRY